AbbVie - Stock Price History | ABBV

Historical daily share price chart and data for AbbVie since 2019 adjusted for splits. The latest closing stock price for AbbVie as of September 18, 2019 is 71.27.
  • The all-time high AbbVie stock closing price was 123.21 on January 26, 2018.
  • The AbbVie 52-week high stock price is 96.60, which is 35.5% above the current share price.
  • The AbbVie 52-week low stock price is 62.66, which is 12.1% below the current share price.
  • The average AbbVie stock price for the last 52 weeks is 79.70.
AbbVie Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 97.4699 98.4100 123.2100 77.8500 92.1900 -4.67%
2017 75.1653 62.4100 98.2100 60.0000 96.7100 54.44%
2016 60.6680 57.6100 67.3900 51.1800 62.6200 5.71%
2015 62.1042 65.8900 71.2300 48.2700 59.2400 -9.47%
2014 55.4601 51.9800 69.7100 46.4600 65.4400 23.92%
2013 43.6623 35.1200 54.3200 33.7100 52.8100 0.00%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $105.859B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $342.221B 14.90
Roche Holding AG (RHHBY) Switzerland $240.930B 0.00
Merck (MRK) United States $211.257B 17.37
Pfizer (PFE) United States $201.883B 11.89
Novartis AG (NVS) Switzerland $198.525B 17.07
Novo Nordisk (NVO) Denmark $120.697B 21.33
AstraZeneca (AZN) United Kingdom $113.163B 21.89
Sanofi (SNY) France $110.933B 13.63
Eli Lilly (LLY) United States $107.279B 20.02
GlaxoSmithKline (GSK) United Kingdom $102.512B 12.88
Bristol-Myers Squibb (BMY) United States $81.363B 11.54
Bayer (BAYRY) Germany $69.195B 10.08
H Lundbeck (HLUYY) Denmark $6.741B 9.73